Acute myeloid leukemia chemotherapy has not reached remission, blindly playing the ascending injection may stimulate the growth of tumor cells, so acute myeloid leukemia patients chemotherapy should be used with caution ascending injection. However, in some chemotherapy regimens, the ascending injection is required to be used in conjunction with chemotherapeutic drugs.
1. During chemotherapy, if the disease itself has not reached remission, the use of ascending white needle may accelerate the proliferation of malignant cells, and even promote the relapse of leukemia, seriously affecting the effect of chemotherapy.
2. However, in some chemotherapy regimens, such as DCAG regimen (decitabine, cytarabine, azulpiride, azulpiridine), ascorbic acid injection needs to be used concurrently with chemotherapeutic agents in order to promote the effect of chemotherapy.
Adverse effects of Ascending White Needle include rash, fever, etc. The drug should be used with caution in patients who are allergic to the drug and those with severe hepatic or renal impairment.
Therefore, the use of ascending white needle is not an absolute contraindication to chemotherapy for acute myeloid leukemia, the specific use of the drug needs to be under the guidance of a physician.